You are here: Industry Insights > COVID-19

News List

Enlivex Doses First Two Patients in Allocetra Trial in Severe COVID-19 Patients americanpharmaceuticalreview
October 29, 2020
Enlivex Therapeutics reported the first two patients have been dosed in an investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
Trial to evaluate oral nitric oxide therapy in COVID-19 patients europeanpharmaceuticalreview
October 29, 2020
The study will establish whether NOviricid can improve COVID-19 patient outcomes and survival in 840 recently diagnosed African American patients with comorbidities.
South Korea pharma Celltrion’s COVID test gets US emergency use authorisation expresspharma
October 28, 2020
The authorisation came three months after requesting approval in late July and the product has already been launched in the United States in August.
ANA Therapeutics initiates trial of oral niclosamide for Covid-19 treatment pharmaceutical-technology
October 28, 2020
Biotech firm ANA Therapeutics has begun Phase II/III trial to analyse the safety and efficacy of its oral niclosamide (ANA001) formulation for treating patients with moderate Covid-19.
Beyond Air to Initiate Nitric Oxide, LungFit Study for Acute Viral Pneumonia, COVID-19 americanpharmaceuticalreview
October 28, 2020
Beyond Air announced it plans to initiate a clinical study of the LungFit? system for evaluation of the safety and efficacy of high concentration inhaled NO given intermittently to adults hospitalized with acute viral pneumonia, including SARS-CoV-2.
Final Report Confirms Remdesivir Benefits for COVID-19 americanpharmaceuticalreview
October 28, 2020
Remdesivir is an antiviral medication that targets a range of viruses. It was originally developed over a decade ago to treat hepatitis C and a cold-like virus called respiratory syncytial virus (RSV). Remdesivir wasn’t an effective treatment for ...
Evgen scores full approval for COVID-19 trial launch pharmatimes
October 28, 2020
Evgen Pharma has received full regulatory approval for its STAR trial, which will investigate the company’s lead asset to treat acute respiratory distress syndrome (ARDS) in patients with suspected COVID-19.
BioCanna Announces A Breakthrough In Development of Its Patent-Pending 'BioNano Virus Detection System' And Announcing the COVID-19 POC Test Kit prnewswire
October 28, 2020
BioCanna Health Care Inc., a leading innovator in pharmaceutical applications of Cannabinoids, Terpenes and other biomaterials, has announced that its wholly owned subsidiary, BioCanna CuraLab, in collaboration with University of Ottawa, has made a ...
COVID-19 containment shaped by strength, duration of natural, vaccine-induced immunity worldpharmanews
October 28, 2020
"Much of the discussion so far related to the future trajectory of COVID-19 has rightly been focused on the effects of seasonality and non-pharmaceutical interventions [NPIs], such as mask-wearing and physical distancing," said co-first author ...
Moderna announces supply agreement with the Ministry of Public Health to supply Qatar with mRNA vaccine against COVID-19 (mRNA-1273) worldpharmanews
October 28, 2020
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273 ..